STOCK TITAN

CME Group officer proposes sale of 655 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
144

Rhea-AI Filing Summary

CME Group Inc. officer John Clifford Marchese filed a notice listing a proposed sale of 655 common shares, with an approximate sale date of November 18, 2026. The notice’s acquisition table lists restricted stock acquired from the issuer on September 15 and September 16, 2025.

Shares proposed for sale 655 shares Approximate sale date: November 18, 2026
Aggregate market value $203,541.25 Securities listed for sale
Shares outstanding 357,930,746 shares Number listed in the notice
Restricted stock acquired 166 shares Acquired from the issuer on September 15, 2025
Restricted stock acquired 178 shares Acquired from the issuer on September 15, 2025
Restricted stock acquired 136 shares Acquired from the issuer on September 16, 2025
Restricted stock acquired 175 shares Acquired from the issuer on September 15, 2025
Restricted Stock financial
"Nature of acquisition: Restricted Stock"
Shares granted to an individual that carry limits on transfer or sale until certain conditions are met, such as staying with the company for a set time or hitting performance targets. Think of them as a locked gift that gradually opens; for investors they matter because they affect how many shares may enter the market later, signal management incentives and potential dilution, and reveal confidence in future company performance.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many CME shares did John Clifford Marchese propose to sell?

The notice lists 655 common shares for sale, with an approximate sale date of November 18, 2026.

What is the stated market value of the proposed CME sale?

The notice reports an aggregate market value of $203,541.25 for the securities listed for sale.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

Keep reading